IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,006,534 | -47.3% | 125,503 | -2.7% | 0.01% | -43.8% |
| Q1 2024 | $1,911,543 | +72.7% | 128,984 | -5.3% | 0.02% | +45.5% |
| Q4 2023 | $1,107,168 | -12.0% | 136,183 | -50.8% | 0.01% | 0.0% |
| Q3 2023 | $1,258,230 | -37.1% | 276,534 | -2.7% | 0.01% | -45.0% |
| Q2 2023 | $2,000,630 | -8.8% | 284,181 | -20.9% | 0.02% | 0.0% |
| Q1 2023 | $2,194,860 | – | 359,224 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
| MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
| Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
| CM Management, LLC | 200,000 | $910,000 | 0.97% |
| Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
| Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
| Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
| Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
| 683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |